Merck Ads vs. Elanco, Freshpet’s Whole Story, BI puts numbers to Vet Experience
Last week of May, what’d you miss in vet med?
- Merck’s Bravetco Quatum Ads under Fire
- Freshpet authorized $150M Share buyback
- Boehringer Ingelheim’s Going Beyond Survey
Helpful links:
